Form 4 for KYNB KYNTRA BIO, INC.

Accepted 2023-06-15 00:00:00 ET · period of report 2023-06-13 · accession 0001209191-23-037604 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-06-15	2023-06-13+	KYNB	Chung Christine	SVP, China Ops	S - Sale	$17.19	-12.5K	236.3K	-5%	-$214.9K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-06-13	S	D	6,250	$17.60	242,577	D	—	—	(F1) Shares sold pursuant to a 10b5-1 trading plan. (F2) The shares were sold at prices ranging from $17.31 to $18.18. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2	Common	Common Stock	2023-06-14	S	D	5,250	$16.66	237,327	D	—	—	(F1) Shares sold pursuant to a 10b5-1 trading plan. (F3) The shares were sold at prices ranging from $16.34 to $17.32. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3	Common	Common Stock	2023-06-14	S	D	1,000	$17.46	236,327	D	—	—	(F1) Shares sold pursuant to a 10b5-1 trading plan. (F4) The shares were sold at prices ranging from $17.37 to $17.61. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.